Literature DB >> 11982824

Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit?

Marion Morena1, Jean-Paul Cristol, Lynne Senécal, Helene Leray-Moragues, Detlef Krieter, Bernard Canaud.   

Abstract

Oxidative stress results from an imbalance between oxidant production, including reactive oxygen species (ROS), reactive nitrogen species (RNS), chlorinated compounds, and antioxidant defense mechanisms. Most reports prove that oxidative stress is present in ESRD patients. Several studies tend to accreditate the hypothesis by which oxidative stress is a strong co-factor for the development of complications related to long-term HD such as atherosclerosis, amyloidosis, malnutrition, anemia, and infection. In order to evaluate the rationale for curative action against oxidative damage in chronic renal failure patients, we reviewed the putative factors involved in this process. Antioxidant systems are severely impaired in uremic patients and gradually altered with the degree of renal failure. Moreover, the inflammatory state caused by the hemoincompatibility of the dialysis system plays a critical role in the activation of NADPH oxidase, aggravating the pro-oxidant status of uremic patients. Prevention of ROS overproduction by improvement of dialysis biocompatibility, an important component of adequate dialysis, might be completed by antioxidant supplementation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982824     DOI: 10.1046/j.1523-1755.61.s80.20.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  24 in total

Review 1.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

2.  Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure.

Authors:  Ewa M Slominska; Katarzyna Kowalik; Ryszard T Smolenski; Marek Szolkiewicz; Przemyslaw Rutkowski; Boleslaw Rutkowski; Julian Swierczynski
Journal:  Pediatr Nephrol       Date:  2006-04-08       Impact factor: 3.714

Review 3.  Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.

Authors:  Stefanie Steiger; Jan Rossaint; Alexander Zarbock; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2021-12-14       Impact factor: 10.121

4.  Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease.

Authors:  Yudan Wei; Jing Lin; Fan Yang; Xiujiang Li; Yue Hou; Ronghua Lu; Xiaonv Shi; Zhi Liu; Yujun Du
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

5.  Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.

Authors:  Nicole Schupp; Eva Maria Dette; Ursula Schmid; Udo Bahner; Michaela Winkler; August Heidland; Helga Stopper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-29       Impact factor: 3.000

6.  Development of a device for chemiluminescence determination of superoxide generated inside a dialysis hollow-fiber membrane.

Authors:  Takehito Ogawa; Sumire Koga; Taiji Yakushiji; Masato Matsuda; Ken-Ichiro Yamamoto; Hiroki Sakata; Makoto Fukuda; Takehiro Miyasaka; Kiyotaka Sakai
Journal:  J Artif Organs       Date:  2010-02-19       Impact factor: 1.731

7.  Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study.

Authors:  Sunil Joshi; Benjamin T Saylor; Wei Wang; Ammon B Peck; Saeed R Khan
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

Review 8.  Immune dysfunction in uremia—an update.

Authors:  Gerald Cohen; Walter H Hörl
Journal:  Toxins (Basel)       Date:  2012-10-24       Impact factor: 4.546

9.  Role of plasma protein and low-molecular weight substances in the change of hydroxyl radical scavenging activity in hemodialysis patients.

Authors:  Akiko Hirakawa; Kazumasa Aoyagi; Motoo Nakajima; Syuichi Kikuchi; Syoji Ohba; Kunihiro Yamagata
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

10.  Venous versus arterial iron administration in haemodialysis. Influence on erythrocytes antioxidant parameters.

Authors:  C B Dogaru; C Capusa; L Gaman; E Torac; D Lixandru; M Gilca; L Iosif; C Muscurel; I Stoian; G Mircescu; V Atanasiu
Journal:  J Med Life       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.